EU Eyeing Opening Markets For Biosimilar, Generic Drugs
The European Union is developing a draft regulation that would allow continent-based makers of generic and biosimilar drugs to manufacture their versions of protected drugs for exportation to foreign markets where...To view the full article, register now.
Already a subscriber? Click here to view full article